Could treatment with immunomodulatory agents targeting IL-1, IL-6, or JAK signalling improve outcomes in patients with severe influenza pneumonia? A systematic and narrative review

MLA

Leanne M C Hays, et al. “Could Treatment with Immunomodulatory Agents Targeting IL-1, IL-6, or JAK Signalling Improve Outcomes in Patients with Severe Influenza Pneumonia? A Systematic and Narrative Review.” HRB Open Research, vol. 5, Nov. 2022, p. 77. EBSCOhost, https://doi.org/10.12688/hrbopenres.13613.1.

APA

Leanne M C Hays, Melissa Black, Michael P Prunty, Srinivas Murthy, Frank L van de Veerdonk, Djillali Annane, Alexandra Binnie, Aidan Burrell, Lennie P G Derde, Anthony C Gordon, Cameron Green, Antoine Guillon, Karuna Keat, Patrick R Lawler, David C Lye, Florian B Mayr, Colin J McArthur, Danny F McAuley, Bryan J McVerry, … Alistair Nichol. (2022). Could treatment with immunomodulatory agents targeting IL-1, IL-6, or JAK signalling improve outcomes in patients with severe influenza pneumonia? A systematic and narrative review. HRB Open Research, 5, 77. https://doi.org/10.12688/hrbopenres.13613.1

Chicago

Leanne M C Hays, Melissa Black, Michael P Prunty, Srinivas Murthy, Frank L van de Veerdonk, Djillali Annane, Alexandra Binnie, et al. 2022. “Could Treatment with Immunomodulatory Agents Targeting IL-1, IL-6, or JAK Signalling Improve Outcomes in Patients with Severe Influenza Pneumonia? A Systematic and Narrative Review.” HRB Open Research 5 (November): 77. doi:10.12688/hrbopenres.13613.1.